On ECHEMI
Home > Drugs > Zhejiang Deyer Pharmaceutical Co., Ltd.
Zhejiang Deyer Pharmaceutical Co., Ltd.
  • Founded in:

    1996-04-05
  • Country:

    China China
  • Address:

    No. 128, Jinqu Road, Jinhua City, Zhejiang Province
  • Tax NO.:

    91330701147288897Y
  • Registered Funds:

    10 million yuan
  • Website:

  • Email:

Related Drugs
Nifedipine Capsules
The main component of this product and its chemical name is: 2,16-dimethyl-4 (2-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylic acid dimethyl ester. Its structural formula is: Molecular formula: C17H18N2O6 Molecular weight: 346.34
Name Description Content CAS NO. Registered Holders
Nifedipine

Dihydropyridine calcium antagonists can selectively inhibit the transmembrane transport of calcium ions into myocardial cells and smooth muscle cells, and inhibit the release of calcium ions from intracellular pools without changing the plasma calcium ion concentration. Pharmacological effects include: 1. It can simultaneously dilate the coronary arteries in the normal blood supply area and the ischemic area, antagonize spontaneous or ergonovine-induced coronary artery spasm, increase the delivery of myocardial oxygen in patients with coronary artery spasm, and relieve and prevent coronary artery spasm; 2. It can inhibit myocardial contraction, reduce myocardial metabolism, and reduce myocardial oxygen consumption; 3. It can dilate peripheral resistance vessels, reduce peripheral resistance, reduce systolic and diastolic blood pressure, and reduce cardiac afterload; 4. It can delay the sinus node function and atrioventricular conduction of the isolated heart; electrophysiological studies of whole animals and humans have not found that this product has the effect of delaying atrioventricular conduction, prolonging the recovery time of the sinus node, and slowing down the sinus node rate.

More

Dihydropyridine calcium antagonists can selectively inhibit the transmembrane transport of calcium ions into myocardial cells and smooth muscle cells, and inhibit the release of calcium ions from intracellular pools without changing the plasma calcium ion concentration. Pharmacological effects include: 1. It can simultaneously dilate the coronary arteries in the normal blood supply area and the ischemic area, antagonize spontaneous or ergonovine-induced coronary artery spasm, increase the delivery of myocardial oxygen in patients with coronary artery spasm, and relieve and prevent coronary artery spasm; 2. It can inhibit myocardial contraction, reduce myocardial metabolism, and reduce myocardial oxygen consumption; 3. It can dilate peripheral resistance vessels, reduce peripheral resistance, reduce systolic and diastolic blood pressure, and reduce cardiac afterload; 4. It can delay the sinus node function and atrioventricular conduction of the isolated heart; electrophysiological studies of whole animals and humans have not found that this product has the effect of delaying atrioventricular conduction, prolonging the recovery time of the sinus node, and slowing down the sinus node rate.

21829-25-4 74
Blood-nourishing Angelica Syrup
Chinese angelica, white peony root, cooked rehmannia root, astragalus root, codonopsis pilosula, poria, chuanxiong, and roasted licorice root.
Name Description Content CAS NO. Registered Holders
Angelicae Sinensis Radix

0
PAEONIAE RADIX ALBA

0
REHMANNIAE RADIX PRAEPARATA

0
Astragali Radix

0
Codonopsis

0
Poria

0
Riligustilide

89354-45-0 0
Licorice root flavonoids saponins polysaccharides polyphenols alkaloids volatile oils

0
Five vitamin oral solution
Vitamin B1, vitamin B2, vitamin B6, etc.
Name Description Content CAS NO. Registered Holders
Thiamine chloride

An important component of coenzymes required for sugar metabolism

More

An important component of coenzymes required for sugar metabolism

59-43-8 9
Riboflavin

Important coenzyme component required for tissue respiration

More

Important coenzyme component required for tissue respiration

83-88-5 19
Nicotinamide

Component of coenzymes I and II, essential for lipid metabolism and oxidation of tissue respiration

More

Component of coenzymes I and II, essential for lipid metabolism and oxidation of tissue respiration

98-92-0 12
Vitamin B6

A cofactor for many enzymes, involved in the metabolism of amino acids and fats

More

A cofactor for many enzymes, involved in the metabolism of amino acids and fats

8059-24-3 11
Calcium D-Pantothenate

Component of coenzyme A, involved in the metabolism of sugar, fat and protein

More

Component of coenzyme A, involved in the metabolism of sugar, fat and protein

137-08-6 8
Qumixin Cream
This product is a compound preparation, and its components are 100 mg of miconazole nitrate, 10 mg of triamcinolone acetonide acetate, and 30,000 units of neomycin sulfate per 10 g.
Name Description Content CAS NO. Registered Holders
Miconazole nitrate

This product is a broad-spectrum antifungal drug. It interferes with the activity of cytochrome P450, inhibits the biosynthesis of ergosterol in fungal cell membranes, damages fungal cells and changes their permeability, leading to leakage of intracellular substances; inhibits the biosynthesis of triglycerides and phospholipids in fungi, inhibits the activity of oxidases and peroxidases, causes accumulation of hydrogen peroxide in cells, leads to cell submicrostructure degeneration and cell necrosis. For Candida albicans, it can inhibit the process of transformation from spores to invasive hyphae.

More

This product is a broad-spectrum antifungal drug. It interferes with the activity of cytochrome P450, inhibits the biosynthesis of ergosterol in fungal cell membranes, damages fungal cells and changes their permeability, leading to leakage of intracellular substances; inhibits the biosynthesis of triglycerides and phospholipids in fungi, inhibits the activity of oxidases and peroxidases, causes accumulation of hydrogen peroxide in cells, leads to cell submicrostructure degeneration and cell necrosis. For Candida albicans, it can inhibit the process of transformation from spores to invasive hyphae.

100mg 22832-87-7 31
Triamcinolone acetonide 21-acetate

It has the anti-inflammatory, anti-allergic and vasoconstrictive effects of topical glucocorticoids.

More

It has the anti-inflammatory, anti-allergic and vasoconstrictive effects of topical glucocorticoids.

10mg 3870-07-3 5
Neomycin sulfate

It has antibacterial effect on Staphylococcus (methicillin-sensitive strains) and Corynebacterium.

More

It has antibacterial effect on Staphylococcus (methicillin-sensitive strains) and Corynebacterium.

30,000unit 1405-10-3 10
Coenzyme Q10 capsules
Coenzyme Q10 chemical name: 2-(3,7,11,15,19,23,27,31,35,39-decylmethyl-2,6,10,14,18,22,26,30,34,38-tetradecenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone. Molecular formula: C59H90O4 Molecular weight: 863.36
Name Description Content CAS NO. Registered Holders
Coenzyme Q10

In acute toxicity experiments, the LD50 in mice and rats was greater than 4000 mg/Kg. In subacute toxicity experiments, Wistar male and female rats were given 40 mg, 200 mg and 1000 mg/Kg per day for 5 weeks, and male and female rabbits were given 6 mg, 60 mg and 600 mg/Kg per day for 23 consecutive days. There were no special changes in the blood, urine and morphological observations of the test animals. In chronic toxicity experiments, Wistar male and female rats were given 6 mg, 60 mg and 600 mg/Kg per day for 26 consecutive weeks. There were no special changes in the general state, blood and urine examinations, and morphological observations of the test animals.

More

In acute toxicity experiments, the LD50 in mice and rats was greater than 4000 mg/Kg. In subacute toxicity experiments, Wistar male and female rats were given 40 mg, 200 mg and 1000 mg/Kg per day for 5 weeks, and male and female rabbits were given 6 mg, 60 mg and 600 mg/Kg per day for 23 consecutive days. There were no special changes in the blood, urine and morphological observations of the test animals. In chronic toxicity experiments, Wistar male and female rats were given 6 mg, 60 mg and 600 mg/Kg per day for 26 consecutive weeks. There were no special changes in the general state, blood and urine examinations, and morphological observations of the test animals.

303-98-0 14
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.